Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Today, the Mesothelioma Applied Research Foundation, among 130 organizations, cancer centers, and other institutions, sent a letter to President Joseph R. Biden, key members of
The Congressionally Directed Medical Research Programs’ (CDMPR), Rare Cancers Research Program (RCRP) consumer advocate Jessica Blackford-Cleeton recently participated in the evaluation of research applications submitted
Marjorie G. Zauderer, MD, discusses a currently enrolling Phase 1 clinical trial for mesothelioma patients. This CAR-T cell therapy trial targets mesothelin, a protein heavily
Heather Von St James’ fifteenth annual Lung Leavin’ Day is virtually taking place Saturday, Feb. 6 to celebrate her 15 years of survivorship. Folks can join via Facebook
Kanwal Raghav, MD, discusses the results of a Phase 2 trial of atezolizumab and bevacizumab in patients with relapsed/refractory and unresectable malignant peritoneal mesothelioma. Dr.
The Mesothelioma Applied Research Foundation recommends Covid-19 vaccinations in mesothelioma patients receiving immunotherapy treatments. We commend the unprecedented development of safe, effective Covid-19 vaccines. It is our hope that these vaccines will end the pandemic, especially for our mesothelioma community
You asked, we listened! As a result of your requests for more information about the legal process as it relates to mesothelioma, we bring you
The Mesothelioma Applied Research Foundation has added a new monthly mesothelioma support group call for those who are under 55 and have lost a spouse to mesothelioma. Claudine Benmar and Gwen Dew,